Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 7,897,813
- Share change
- +1,792,949
- Total reported value
- $37,958,000
- Price per share
- $5.00
- Number of holders
- 24
- Value change
- +$8,366,763
- Number of buys
- 16
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.2%
|
1,940,458
|
$10,381,000 | — | 31 Dec 2016 | |
| FMR LLC |
13F
|
Company |
3%
|
1,797,811
|
$9,618,000 | — | 31 Dec 2016 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.5%
|
912,610
|
$4,882,000 | — | 31 Dec 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.62%
|
368,500
|
$1,971,000 | — | 31 Dec 2016 | |
| Boxer Capital, LLC |
13F
|
Company |
0.49%
|
291,230
|
$1,558,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.24%
|
145,472
|
$779,000 | — | 31 Dec 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.24%
|
142,000
|
$760,000 | — | 31 Dec 2016 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.23%
|
135,800
|
$727,000 | — | 31 Dec 2016 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.21%
|
125,000
|
$669,000 | — | 31 Dec 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
100,000
|
$535,000 | — | 31 Dec 2016 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.11%
|
65,000
|
$348,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
52,976
|
$283,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.05%
|
27,319
|
$146,000 | — | 31 Dec 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
14,324
|
$77,000 | — | 31 Dec 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
6,000
|
$32,000 | — | 31 Dec 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,760
|
$20,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,982
|
$16,000 | — | 31 Dec 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
2,978
|
$16,000 | — | 31 Dec 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
1,457
|
$8,000 | — | 31 Dec 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
941
|
$5,000 | — | 31 Dec 2016 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q1 2017
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.